These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 68981)

  • 1. In vitro induction of tumor-specific immunity. VI: analysis of specificity of immune response by cellular competitive inhibition: limitations and advantages of the technique.
    Chism SE; Burton RC; Grail DL; Bell PM; Warner NL
    J Immunol Methods; 1977; 16(3):245-62. PubMed ID: 68981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
    Gorczynski RM; Knight RA
    Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the induction and expression of T cell-mediated immunity. IV. Non-overlapping populations of alloimmune cytotoxic lymphocytes with specificity for tumor-associated antigens and transplantation antigens.
    Kedar E; Bonavida B
    J Immunol; 1975 Nov; 115(5):1301-8. PubMed ID: 51889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
    Herberman RB; Nunn ME; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):216-29. PubMed ID: 50294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens.
    Chism SE; Burton RC; Warner NL
    J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor immunity to murine plasma cell tumors. III. Detection of common and unique tumor-associated antigens on BALB/c, C3H, and NZB plasmacytomas by in vivo and in vitro induction of tumor-immune responses.
    Burton RC; Warner NL
    J Natl Cancer Inst; 1977 Mar; 58(3):701-9. PubMed ID: 300112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.
    Burton RC; Warner NL
    Br J Cancer; 1978 Feb; 37(2):159-70. PubMed ID: 75739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro.
    Ilfeld D; Carnaud C; Cohen IR; Trainin N
    Int J Cancer; 1973 Jul; 12(1):213-22. PubMed ID: 4133584
    [No Abstract]   [Full Text] [Related]  

  • 12. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
    Shain B; Holt CA; Lilly F
    J Immunol; 1982 Aug; 129(2):722-9. PubMed ID: 6177779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells.
    Tamerius JD; Garrigues HJ; Hellström I; Hellström KE
    J Immunol Methods; 1978; 22(1-2):1-22. PubMed ID: 78950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific blocking factors--are they important?
    Hellström KE; Hellström I; Nepom JT
    Biochim Biophys Acta; 1977 Dec; 473(2):121-48. PubMed ID: 73383
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro sensitization and induction of syngeneic tumor--specific cell--mediated cytotoxicity.
    Ferguson RM; Moe M; Simmons RL
    Surg Forum; 1976; 27(62):117-9. PubMed ID: 1032910
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic changes of DBA/2J mastocytoma cells when grown in the BALB/c mouse.
    Wolf JE; Faanes RB; Choi YS
    J Natl Cancer Inst; 1977 May; 58(5):1407-12. PubMed ID: 67213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separable populations of activated thymus-derived lymphocytes identified in two assays for cell-mediated immunity to murine tumor allografts.
    Tigelaar RE; Gorczynski RM
    J Exp Med; 1974 Jul; 140(1):267-89. PubMed ID: 4545897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity against tumour-associated antigens not H-2 restricted.
    Holden HT; Herberman RB
    Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.